ABT vs GEHC · P/E 25, rev $44.33B vs P/E 15, rev $20.63B
Abbott Laboratories (ABT) versus GE HealthCare Technologies Inc. (GEHC) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
GE HealthCare Technologies Inc. (GEHC) is a medical devices company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported GEHC revenue for 2025-12-31 was $20.63B. Net income was $2.08B. Revenue was up 4.8% from 2024-12-31 to 2025-12-31. GEHC currently screens at market cap $27.82B and trailing P/E 14.7.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. GEHC currently screens at market cap $27.82B and trailing P/E 14.7.
Not investment advice. Open the ABT and GEHC stock pages for the full models.
Not investment advice.